How is Yescarta administered?

Drugs.com

Official answer

by Drugs.com

Yescarta is given through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes. It is given as a one-time infusion. Yescarta is administered only in a certified healthcare facility. It is a special infusion made just for you using your own white blood cells.

  • Before you get Yescarta, you will get 3 days of chemotherapy to prepare your body.
  • After the infusion, you will be monitored where you received your treatment daily for at least 7 days.
  • While you may be discharged from the facility, you will need to remain close-by for at least 4 weeks after receiving Yescarta. Your healthcare providers will monitor you for side effects.
  • If side effects become serious after discharge, you may need to be readmitted to the facility for monitoring.
  • Your healthcare provider will want to do blood tests to follow your progress. If you miss an appointment, call your doctor to reschedule right away.

    • What is Yescarta approved for?

  • Yescarta (axicabtagene ciloleucel), from Kite Pharma, is a chimeric antigen receptor T cell (CAR T) therapy used for adults with large B-cell lymphoma or follicular lymphoma (FL) after failing at least two other systemic treatments. Large B-cell lymphoma and follicular lymphoma are two types of non-Hodgkin lymphoma.
  • It is also approved for patients with large B-cell lymphoma who are refractory (have not responded) to first-line chemoimmunotherapy or that relapse (cancer returns) within 12 months of first-line chemoimmunotherapy.
  • The use for follicular lymphoma is approved under FDA accelerated approval based on response rate. Continued approval for this indication may depend upon the clinical benefit seen in confirmatory trials.

    • Yescarta is a biologic-type of living drug which is manufactured specifically for each patient from their own white blood cells. The receipt of CAR T-cell therapy is a one-time procedure, and the CAR-T cells may continue to replicate in the body to fight the cancer.

    How is Yescarta made?

    Here's the general process for CAR T-cell development:

  • First, leukapheresis (loo-kah-fur-ee-sis), a procedure to collect the patient's white blood cells (lymphocytes), is performed in the hospital, and then the T-cells are isolated. The T-cells are white blood cells used for immune responses.
  • The T-cells are sent to lab where they are genetically engineered to construct a chimeric antigen receptor (CAR) on the cell surface. Genes are inserted into the T-cells using an inactive virus which allows the CAR T-cell to recognize, activate, and kill the lymphoma cells.
  • The CAR T-cell is grown in the lab for about 2 weeks to greatly increase the dose. The cells are frozen and then sent to the hospital for re-infusion to the patient.
  • In the mean time, the patient will receive 3 days of chemotherapy to help lower the white blood cell count and allow the CAR T-cells to be better accepted by the body.

    • This is not all the information you need to know about Yescarta (axicabtagene ciloleucel) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Yescarta information here, and discuss this information and any questions you have with your doctor or other health care provider.

    Related medical questions

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords

    AI Assitant